Teladoc HealthTDOC
TDOC
0
Funds holding %
of 7,398 funds
0
Analysts bullish %
of 5 analysts
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
44% more first-time investments, than exits
New positions opened: 78 | Existing positions closed: 54
13% more call options, than puts
Call options by funds: $65.6M | Put options by funds: $58.3M
11% more repeat investments, than reductions
Existing positions increased: 111 | Existing positions reduced: 100
5% more funds holding
Funds holding: 358 [Q3] → 375 (+17) [Q4]
0% more capital invested
Capital invested by funds: $1.16B [Q3] → $1.16B (+$354K) [Q4]
0.09% less ownership
Funds ownership: 73.89% [Q3] → 73.8% (-0.09%) [Q4]
100% less funds holding in top 10
Funds holding in top 10: 2 [Q3] → 0 (-2) [Q4]
Research analyst outlook
5 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$12
55%
upside
Avg. target
$12.50
61%
upside
High target
$13.50
74%
upside
5 analyst ratings
4 positive
80%
1 neutral
20%
0 negative
0%
Goldman Sachs David Roman 30% 1-year accuracy 6 / 20 met price target | 68%upside $13 | Buy Maintained | 3 Mar 2025 |
Piper Sandler Jessica Tassan 38% 1-year accuracy 9 / 24 met price target | 55%upside $12 | Overweight Maintained | 27 Feb 2025 |
B of A Securities Allen Lutz 73% 1-year accuracy 11 / 15 met price target | 74%upside $13.50 | Neutral Maintained | 12 Feb 2025 |
RBC Capital Sean Dodge 31% 1-year accuracy 11 / 35 met price target | 55%upside $12 | Outperform Maintained | 24 Jan 2025 |
Oppenheimer Michael Wiederhorn 17% 1-year accuracy 5 / 29 met price target | 55%upside $12 | Outperform Maintained | 24 Jan 2025 |
Financial journalist opinion
Based on 28 articles about TDOC published over the past 30 days
Positive
The Motley Fool
2 days ago
Should Investors Buy These 2 Beaten-Down Artificial Intelligence (AI) Healthcare Stocks?
Artificial intelligence (AI) is changing the world. Corporations are racing to establish themselves as leaders in the field, while investors want to cash in by putting their hard-earned money into the most promising AI companies.

Negative
Zacks Investment Research
4 days ago
Why Is Teladoc (TDOC) Down 9.9% Since Last Earnings Report?
Teladoc (TDOC) reported earnings 30 days ago. What's next for the stock?

Negative
Zacks Investment Research
5 days ago
Teladoc (TDOC) Flat As Market Sinks: What You Should Know
Teladoc (TDOC) reachead $8.64 at the closing of the latest trading day, reflecting no change compared to its last close.

Neutral
Zacks Investment Research
1 week ago
Teladoc (TDOC) Exceeds Market Returns: Some Facts to Consider
In the latest trading session, Teladoc (TDOC) closed at $8.49, marking a +1.19% move from the previous day.

Neutral
Accesswire
1 week ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teladoc Health, Inc. - TDOC
NEW YORK, NY / ACCESS Newswire / March 19, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Teladoc Health, Inc. ("Teladoc" or the "Company") (NYSE:TDOC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.

Neutral
PRNewsWire
2 weeks ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teladoc Health, Inc. - TDOC
NEW YORK , March 17, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Teladoc Health, Inc. ("Teladoc" or the "Company") (NYSE: TDOC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.

Neutral
The Motley Fool
2 weeks ago
Does Teladoc's $65 Million Acquisition of Catapult Health Make the Stock a Buy?
Telemedicine specialist Teladoc Health (TDOC 1.53%) has been a terrible investment over the past three years. Once the company's pandemic-fueled business boom cooled down, its revenue and visit growth slowed down considerably while it remained unprofitable.

Neutral
Accesswire
2 weeks ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teladoc Health, Inc. - TDOC
NEW YORK, NY / ACCESS Newswire / March 15, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Teladoc Health, Inc. ("Teladoc" or the "Company") (NYSE:TDOC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.

Positive
Zacks Investment Research
2 weeks ago
Teladoc Expands Specialty Care Access With Carrum Health Partnership
TDOC partners with Carrum Health in a bid to expand access to specialty care.

Neutral
Accesswire
2 weeks ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teladoc Health, Inc. - TDOC
NEW YORK, NY / ACCESS Newswire / March 13, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Teladoc Health, Inc. ("Teladoc" or the "Company") (NYSE:TDOC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.

Charts implemented using Lightweight Charts™